NEW YORK, November 28, 2017 /PRNewswire/ --
In keeping with the commitment to dynamically provide members
with timely information WallStEquities.com has issued free tailored
Stock Review on ACHC, DVA, HLS, and MD which is a click away at
http://www.wallstequities.com/registration. Pre-market today,
WallStEquities.com scans Acadia Healthcare Co. Inc. (NASDAQ:
ACHC), DaVita Inc. (NYSE: DVA), HealthSouth Corp. (NYSE: HLS), and
MEDNAX Inc. (NYSE: MD). Specialized Health Services companies
produce and distribute varying paper products to customers and
businesses of all shapes and sizes. On average, the dividend yields
of these firms tend to be slightly above the market average. With
Wall St. Equities' free research reports get an edge over stock
markets, sign up now at:
http://www.wallstequities.com/registration
Acadia Healthcare
Franklin, Tennessee
headquartered Acadia Healthcare Co. Inc.'s shares gained 2.24%,
closing Monday's trading session at $31.04. The stock recorded a trading volume of
1.11 million shares. The Company's shares are trading 19.30% below
their 50-day moving average. Additionally, shares of Acadia
Healthcare, which develops and operates inpatient psychiatric
facilities, residential treatment centers, group homes, substance
abuse facilities, and outpatient behavioral healthcare facilities
to serve the behavioral health and recovery needs of communities in
the US, the UK, and Puerto Rico,
have a Relative Strength Index (RSI) of 41.11.
On November 03rd, 2017,
research firm Credit Suisse initiated a 'Neutral' rating on the
Company's stock. Our free and thorough report on ACHC awaits you
at:
http://www.wallstequities.com/registration/?symbol=ACHC
DaVita
On Monday, shares in Denver,
Colorado headquartered DaVita Inc. recorded a trading volume
of 2.89 million shares, which was above their three months average
volume of 2.19 million shares. The stock climbed 1.47%, ending the
day at $57.99. The Company's shares
have advanced 1.17% in the previous three months. The stock is
trading lightly below its 50-day moving average by 0.15%.
Furthermore, shares of DaVita, which provides kidney dialysis
services for patients suffering from chronic kidney failure or end
stage renal disease, have an RSI of 54.08.
On November 03rd, 2017,
DaVita Kidney Care, a division of
DaVita, announced its strong support for the Dialysis PATIENTS
Demonstration Act ("PATIENTS Act") (H.R. 4143 / S. 2065).
Integrated care programs, such as the PATIENTS Act, offer patients
added benefits like access to a care coordination team and
medically necessary transportation. This legislation combines
precedents established from Accountable Care Organizations and
Medicare Advantage to enhance the integrated care model for
dialysis patients.
On November 08th, 2017,
research firm RBC Capital Markets reiterated its 'Sector Perform'
rating on the Company's stock with a decrease of the target price
from $64 a share to $60 a share. DVA complimentary research coverage
a few simple steps away at:
http://www.wallstequities.com/registration/?symbol=DVA
HealthSouth
Birmingham, Alabama
headquartered HealthSouth Corp.'s stock finished the day 1.99%
lower at $48.18 with a total trading
volume of 698,543 shares. The Company's shares have advanced 8.81%
in the last one month, 8.64% in the previous three months, and
16.83% on an YTD basis. The stock is trading above its 50-day and
200-day moving averages by 3.77% and 6.81%, respectively.
Additionally, shares of HealthSouth, which provides facility-based
and home-based post-acute healthcare services in the US, have an
RSI of 52.46. Register for your free research report on HLS at:
http://www.wallstequities.com/registration/?symbol=HLS
MEDNAX
Shares in Sunrise, Florida
headquartered MEDNAX Inc. ended yesterday's session 1.57% lower at
$48.33. The stock recorded a trading
volume of 1.29 million shares. The Company's shares have advanced
11.13% in the last one month and 9.47% over the previous three
months. The stock is trading 9.44% above its 50-day moving average.
Moreover, shares of MEDNAX, which together with its subsidiaries,
provides neonatal, anesthesia, maternal-fetal, and other pediatric
subspecialties physician services in the US and Puerto Rico, have an RSI of 58.52.
On November 22nd, 2017,
MEDNAX announced that it will present at the Bank of America
Merrill Lynch 2017 Leveraged Finance Conference on November 29th, 2017, at 2:10 p.m. ET in Boca
Raton. The Company will also present at the Citi 2017 Global
Healthcare Conference on December
06th, 2017, at 2:10 p.m.
ET in New York. A live
audio webcast of both presentations will be available on the
Company's investor website. Wall St. Equities' downloadable
research report on MD available at:
http://www.wallstequities.com/registration/?symbol=MD
--
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and
non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ
and micro-cap stocks. WSE has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the
other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated
investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
WSE has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a
third-party research service company (the "Reviewer") represented
by a credentialed financial analyst [for further information on
analyst credentials, please email info@wallstequities.com.
Rohit Tuli, a CFA® charterholder
(the "Sponsor"), provides necessary guidance in preparing the
document templates. The Reviewer has reviewed and revised the
content, as necessary, based on publicly available information
which is believed to be reliable. Content is researched, written
and reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author
according to the procedures outlined by WSE. WSE is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content
outside of this document has no association with the Author or the
Reviewer in any way.
NO WARRANTY
WSE, the Author, and the Reviewer are not responsible for any
error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is
accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. WSE, the Author, and the
Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, WSE, the Author, and the Reviewer do not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither WSE nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
https://wallstequities.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly.
If you're a company, we are
covering and wish to no longer feature on our coverage list contact
us via email and/or phone between 09:30 EDT
to 16:00 EDT from Monday to Friday at:
Email: info@wallstequities.com
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore
228
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Wall St. Equities